ADDUCT PHARMA

Serial Number 88243984
Registration 6082137
700

Registration Progress

Application Filed
Dec 28, 2018
Under Examination
Approved for Publication
Published for Opposition
Registered
Jun 16, 2020

Attorney Assistance

Section 8 Declaration Due (Supplemental Register) (Based on registration date 20200616)
Due: Jun 16, 2026 175 days

Trademark Image

ADDUCT PHARMA

Basic Information

Serial Number
88243984
Registration Number
6082137
Filing Date
December 28, 2018
Registration Date
June 16, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 16, 2020
Registration
Registered
Classes
042

Rights Holder

MTI Biotech, Incorporated

03
Address
2711 South Loop Drive, Suite 4400
Ames, IA 50010

Ownership History

MTI Biotech, Incorporated

Original Applicant
03
Ames, IA

MTI Biotech, Incorporated

Original Registrant
03
Ames, IA

Legal Representation

Attorney
Emily Harris

USPTO Deadlines

Next Deadline
175 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20200616)
Due Date
June 16, 2026
Grace Period Ends
December 16, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Jun 16, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 16, 2020 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
May 9, 2020 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 7, 2020 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
May 7, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 7, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 7, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 7, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 21, 2020 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Mar 11, 2020 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Mar 10, 2020 IUAA P USE AMENDMENT ACCEPTED Loading...
Mar 10, 2020 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Mar 6, 2020 IUAF S USE AMENDMENT FILED Loading...
Mar 6, 2020 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Oct 21, 2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 21, 2019 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 21, 2019 CNFR R FINAL REFUSAL WRITTEN Loading...
Sep 24, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 23, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 23, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 10, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 10, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 5, 2019 ALIE A ASSIGNED TO LIE Loading...
Aug 30, 2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Mar 21, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 21, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 21, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 19, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 1, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of PHARMACEUTICALS, NUTRACEUTICALS, AND NUTRITIONAL SUPPLEMENTS; Research and development in the pharmaceutical and biotechnology fields
First Use Anywhere: Feb 3, 2020
First Use in Commerce: Feb 3, 2020

Additional Information

Pseudo Mark
ADDUCT PHARMACY

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"